Earnings season is a good time to check in on the most prominent medtech companies in the public sector to see what kind of a quarter they had and what rest of the year looks like for the industry.

Please note, however, that most of the commentary on the following slides came out of fourth-quarter earnings calls that were held before the coronavirus (COVID-19) had spread beyond China. We expect CEOs to paint a much different picture of the COVID-19 business impact during future earnings calls. For more current insight on how the new virus could impact medical device companies in 2020, see this story: The Biggest Threat to Medical Device Revenue Growth During the Pandemic.